Outcomes of Week-24 Completers and Subjects Who Had Follow-Up Beyond Week 24 After a Single Treatment of DaxibotulinumtoxinA for Injection (RT002): Results of a Phase 2, Open-Label (Level II), Dose Escalating Study in Isolated Cervical Dystonia (P5.037)